Ascletis Pharma Inc. announces dosing of 24 healthy subjects of the first 3 cohorts in multiple-dose escalation Phase I clinical trial of oral RNA-dependent...
Mission Bio, the pioneer in single-cell DNA and multi-omics analysis, announced the availability of the Tapestri VCN Assay, the first high-throughput commercial single-cell assay...
BioLink Life Sciences of Cary, North Carolina, today announced receiving a contract from BARDA (the Biomedical Advanced Research and Development Authority) to fund the...
CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc, announced the latest funding award under CEPI's to...
